Edinburgh Cancer Research Centre

From WikiMD's WELLNESSPEDIA

Edinburgh Cancer Research Centre (ECRC) is a leading cancer research institution located in Edinburgh, Scotland. The centre is dedicated to the study and treatment of cancer, with a focus on translating laboratory discoveries into clinical applications.

History[edit]

The ECRC was established in 2001 as a collaborative effort between the University of Edinburgh and Cancer Research UK. The centre's founding was driven by the need for a dedicated facility to conduct high-quality cancer research and to translate these findings into new therapies for patients.

Research[edit]

The ECRC conducts research across a broad range of cancer types, including breast cancer, lung cancer, prostate cancer, and colorectal cancer. The centre's research is divided into several key areas:

  • Molecular Pathology and Genomics: This area of research focuses on understanding the genetic and molecular changes that drive cancer development and progression.
  • Cancer Therapeutics: Researchers in this area are developing new drugs and therapies to treat cancer, with a focus on targeted therapies that can specifically kill cancer cells.
  • Cancer Biology: This research area is focused on understanding the basic biology of cancer, including how cancer cells grow and divide, and how they interact with their environment.

Facilities[edit]

The ECRC is housed in a state-of-the-art facility that includes laboratories, offices, and meeting spaces. The centre also has access to a range of core facilities, including a genomics facility, a proteomics facility, and a bioinformatics facility.

Collaboration[edit]

The ECRC collaborates with a number of other research institutions and organisations, both within the UK and internationally. These collaborations aim to accelerate the pace of cancer research and to bring new treatments to patients more quickly.

See also[edit]

References[edit]


Edinburgh Cancer Research Centre[edit]

Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.